Skip to main content

Table 1 Patient characteristics and outcomes

From: Platelet-derived sCD40L: specific inflammatory marker for early-stage severe acute respiratory syndrome coronavirus 2 infection

  All patients (N = 29) Convalescent patients (N = 26)
Age—years 57 (54–68) 37.6 (22–57)
Sex   
Female 8 (27.6%) 7 (26.9%)
Male 21 (72.4%) 19 (73.1%)
BMI—kg/m2 27.9 (24.4–31.5) N/C
Days from illness onset to first blood sampling—days 11 (9–13) N/A
SAPS II score on day 1 27 (16–35) N/A
SOFA score on day 1 2 (1–8) N/A
Platelet count on day 1–109/L 219 (153–260) N/A
Lymphocyte count on day 1–109/L 0.8 (0.6–1.1) N/A
Invasive ventilation 13 (44.8%) N/A
ARDS 14 (48.3%) N/A
Most pathological PaO2/FiO2 156 (89–238) N/A
Acute renal failure 8 (27.6%) N/A
Septic shock 2 (6.9%) N/A
Thromboembolic event 4 (13.8%) N/A
Hospital length of stay—days 11 (7–19) N/A
ICU length of stay—days 4 (2–13) N/A
Hospital death 1 (3.4%) N/A
  1. Results are presented as n (%) or median (IQR)
  2. BMI, body mass index; SAPS II, Simplified Acute Physiology Score II; PaO2, arterial oxygen tension; FiO2, Fraction of Inspired Oxygen
  3. N/C: Data not collected
  4. N/A: Not applicable